ロード中...
Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
BACKGROUND: Gliomas are the most common primary tumors in central nervous system. The prognosis of the patients with glioma is poor regardless of the development of therapeutic strategies. Its aggressive behavior mainly depends on the potent ability of proliferation. The transcription factor EGR1 (e...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5732438/ https://ncbi.nlm.nih.gov/pubmed/29246166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0656-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|